高用量と低用量セフトリアキソン療法の比較効果: 系統的レビューとメタ分析
Lindsay Brust-Sisti1,2, Gwang-Yee Hu1,3, Matthew Bridgeman4
1Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, USA.
The Annals of pharmacotherapy
|August 28, 2025
まとめ
静脈内投与のセフトリアキソン (Ceftriaxone,CRO) の高用量は,中枢神経系以外の感染症の臨床治癒,入院期間,または死亡率を改善しませんでした. このメタ解析は,標準の1gの投与量が多くの成人の患者にとって十分であることを示唆している.
科学分野:
- 感染症
- 薬理学について
- 臨床薬局
背景:
- Ceftriaxone (CRO) は,広く使用されている第3世代のセファロスポリン抗生物質です.
- 成人の非中枢神経系 (CNS) 感染症に対するセフトリアキソンの最適な投与量は,臨床的な議論の対象となっている.
- 現在推奨されている投与量は様々で,一部の臨床医は1日1g以上の静脈注射 (IV) を選択しています.
研究 の 目的:
- 成人の非中枢神経系感染症の治療において,標準的な1gの1日1回のセフトリアキソンと,より高い用量の有効性と安全性を体系的に比較する.
- 臨床的治癒率,入院期間,死亡率に対する異なるセフトリアキソン投与法の影響を評価する.
- 標準用量と比較して,セフトリアキソンより高い用量に関連した安全性プロファイルと毒性を評価する.
主な方法:
- PubMed,Embase,Scopus,Web of Scienceのデータベースで包括的な文献検索が行われました.
- 含まれていた研究は,ランダム化制御試験 (RCT) と,セフトリアキソン1gを1日1回,より高い用量と比較した観察試験でした.
- メタアナリシスは,Mantle- Haenszelランダム効果モデルを使用して,Peto確率比 (pOR) と臨床治癒,滞在期間,および死亡率の標準差を計算した.
主要な成果:
- 5145人の患者を対象とした8つの研究がメタ解析に含まれていた.
- 臨床治癒 (pOR 0. 958; 95% CI [0. 525 - 1. 749]),入院期間 (SMD 0. 052; 95% CI [- 0. 418, 0. 523]),または死亡率 (pOR 0. 932; 95% CI [- 0. 789 - 1. 100]) に関する統計学的に有意な差異は認められなかった.
- 臨床的治癒と滞在期間において有意な異質性が認められ,含まれている研究間の変動性を示した.
結論:
- 1日1gを超えるセフトリアキソン投与は,臨床治癒の改善,入院期間の短縮,または成人におけるCNS以外の感染症における死亡率の低下を示さなかった.
- 標準的な1gのIV投与は,多くの非CNS感染症の有効性と安全性のために十分な可能性があることを示唆しています.
- これらの研究結果を確認し,特定の患者集団や,薬理学的な変化が要因となる感染症のタイプにおける最適な投与量を調査するために,さらなる前向きな研究が推奨されます.
さらに関連する動画
関連する概念動画
01:22Dose-Response Relationship: Potency and Efficacy
5.2K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
5.2K
01:27Combined Effects of Drugs: Synergism
4.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.7K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
01:28Antimicrobial Effectiveness
156
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
156
01:15Drug Dosage Regimen: Overview
3.8K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.8K
01:01Dosage Regimen: Fixed Dose
2.0K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.0K